DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
International Collaborative Ovarian Neoplasm Group.
Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: The ICON3 randomised trial.
Lancet 2002;
360: 505-15
We do not assume any responsibility for the contents of the web pages of other providers.